Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of ketamine-associated vomiting in children undergoing laceration repair
IRCT20180129038549N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ondansetron and ketamine in Nausea and Vomiting (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Incidence of nausea and vomiting in the emergency department. Started Jan 2018; status: completed.
02
Drugs
ondansetronketamine
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on IRCT20180129038549N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180129038549N1.